At Capital Surgeons Group, our team of board-certified surgeons, nutritionists, and medical weight loss experts helps you choose the safest and most effective path for lasting results tailored to your goals, lifestyle, and medical history
Researchers are already testing triple-agonist drugs, such as retatrutide, which target GLP-1, GIP and glucagon receptors
A dual GIP and GLP-1 receptor agonist peptide in a 30mg vial
The metabolic effects of tirzepatide complement thyroid hormone replacement rather than conflicting with it, provided the interaction is properly managed through monitoring and dose adjustment
Christin Glorioso, MD PhD Dr